Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$29.66 - $44.0 $169,951 - $252,120
-5,730 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$43.09 - $82.26 $246,905 - $471,349
5,730 New
5,730 $247,000
Q1 2019

Apr 18, 2019

SELL
$90.12 - $152.23 $382,649 - $646,368
-4,246 Closed
0 $0
Q4 2018

Jan 25, 2019

SELL
$112.83 - $239.74 $138,555 - $294,400
-1,228 Reduced 22.43%
4,246 $527,000
Q3 2018

Oct 17, 2018

SELL
$189.1 - $282.92 $122,158 - $182,766
-646 Reduced 10.56%
5,474 $1.45 Million
Q2 2018

Jul 27, 2018

SELL
$123.8 - $192.48 $204,517 - $317,976
-1,652 Reduced 21.26%
6,120 $1.14 Million
Q1 2018

Apr 06, 2018

BUY
$114.22 - $133.22 $27,983 - $32,638
245 Added 3.25%
7,772 $955,000
Q4 2017

Jan 25, 2018

BUY
$93.4 - $128.74 $276,650 - $381,327
2,962 Added 64.88%
7,527 $896,000
Q3 2017

Oct 03, 2017

BUY
$91.08 - $104.49 $415,780 - $476,996
4,565
4,565 $434,000

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $241M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.